However, interestingly, it has also been demonstrated that inhibition of just Hsp70 considerably modifies and severely damages the Hsp90 chaperone system, pointing to Hsp70 as a new therapeutic objective for melanoma [30,79]. This evidence concerns the gene HSPA1A and melanoma.